Evidence map›Paper›PMID 41903117›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Phenotypic Diversity and Outcomes in Pediatric NMDA Receptor Encephalitis: A 15-Year Retrospective Study from the Largest Children's Hospital in the United States.

Alexander J Sandweiss, Timothy Erickson, Yike Jiang, Varun Kannan, Jonathan M Yarimi, Kristen S Fisher, Nikita Shukla, Tim Lotze, Eyal Muscal, Kristy O Murray

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexander J SandweissDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-8213-2941
Timothy EricksonLaboratories for Emerging and Tropical Diseases, School of Public Health, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0002-5490-8845
Yike JiangDepartment of Pediatrics, Division of Pediatric Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-1921-2874
Varun KannanDepartment of Pediatrics, Division of Pediatric Neurology, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-9783-4401
Jonathan M YarimiMemorial Division of Pediatric Neurology, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.ORCID https://orcid.org/0000-0003-0246-9964
Kristen S FisherDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-1598-8571
Nikita ShuklaDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-7322-676X
Tim LotzeDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID https://orcid.org/0009-0003-2898-1963
Eyal MuscalDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-1866-6129
Kristy O MurrayDepartment of Pediatrics, Division of Innovation and Research, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-6921-3413

Funding

Research Vision at Texas Children's Hospital
6 · The paper itself

Abstract

Anti-NMDAR encephalitis (NMDARE) is an autoantibody-mediated disorder characterized by seizures, movement disorders, neurocognitive deficits, and psychosis, but the complete phenotypic heterogeneity, and outcomes are incompletely understood in children. This single-center retrospective analysis of NMDARE at the largest pediatric hospital in the United States between 2009 and 2024 screened 115 patients diagnosed with NMDARE. 103 had sufficient clinical data available for analyses. Two-thirds were Hispanic, disproportionate to the Houston metro area demographics, and Hispanic patients had a higher CSF white cell count and antibody titer. Approximately one-half of the patients with idiopathic NMDARE presented with a focal cortical phenotype that localized to the perisylvian region as initial symptomology, which we describe as a "perisylvian phenotype." Patients with teratomas had more severe early symptoms, earlier lumbar punctures, higher CSF white cell counts, earlier treatment, and longer hospital durations than HSVE and idiopathic patients. CSF antibody titers directly correlated to hospital length of stay and mRS at presentation through 12-month follow up, and normal routine CSF studies and brain MRI delayed initiation of first-line immunotherapy. These novel and corroborating observations serve as the foundation for future studies on early focal neurological deficits (i.e., perisylvian phenotype) that must be addressed by clinicians to prevent delay in care.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisAdolescentAutoantibodiesChildChild, PreschoolFemaleHospitals, PediatricHumansInfantMalePhenotypeRetrospective StudiesUnited StatesAutoantibodiesautoimmune encephalitisneuroimmunologyneuroinflammationpediatric neurology

Identifiers

PMID41903117
PMCPMC13185876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.